COVID-19 at War: The Joint Forces Operation in Ukraine.


Journal

Disaster medicine and public health preparedness
ISSN: 1938-744X
Titre abrégé: Disaster Med Public Health Prep
Pays: United States
ID NLM: 101297401

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 26 3 2021
medline: 2 11 2022
entrez: 25 3 2021
Statut: ppublish

Résumé

The ongoing pandemic disaster of coronavirus erupted with the first confirmed cases in Wuhan, China, in December 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) novel coronavirus, the disease referred to as coronavirus disease 2019, or COVID-19. The World Health Organization (WHO) confirmed the outbreak and determined it a global pandemic. The current pandemic has infected nearly 300 million people and killed over 3 million. The current COVID-19 pandemic is smashing every public health barrier, guardrail, and safety measure in underdeveloped and the most developed countries alike, with peaks and troughs across time. Greatly impacted are those regions experiencing conflict and war. Morbidity and mortality increase logarithmically for those communities at risk and that lack the ability to promote basic preventative measures. States around the globe struggle to unify responses, make gains on preparedness levels, identify and symptomatically treat positive cases, and labs across the globe frantically rollout various vaccines and effective surveillance and therapeutic mechanisms. The incidence and prevalence of COVID-19 may continue to increase globally as no unified disaster response is manifested and disinformation spreads. During this failure in response, virus variants are erupting at a dizzying pace. Ungoverned spaces where nonstate actors predominate and active war zones may become the next epicenter for COVID-19 fatality rates. As the incidence rates continue to rise, hospitals in North America and Europe exceed surge capacity, and immunity post infection struggles to be adequately described. The global threat in previously high-quality, robust infrastructure health-care systems in the most developed economies are failing the challenge posed by COVID-19; how will less-developed economies and those health-care infrastructures that are destroyed by war and conflict fare until adequate vaccine penetrance in these communities or adequate treatment are established? Ukraine and other states in the Black Sea Region are under threat and are exposed to armed Russian aggression against territorial sovereignty daily. Ukraine, where Russia has been waging war since 2014, faces this specific dual threat: disaster response to violence and a deadly infectious disease. To best serve biosurveillance, aid in pandemic disaster response, and bolster health security in Europe, across the North Atlantic Treaty Alliance (NATO) and Black Sea regions, increased NATO integration, across Ukraine's disaster response structures within the Ministries of Health, Defense, and Interior must be reinforced and expanded to mitigate the COVID-19 disaster.

Identifiants

pubmed: 33762057
pii: S1935789321000884
doi: 10.1017/dmp.2021.88
pmc: PMC8160495
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1753-1760

Auteurs

John M Quinn V (JM)

Charles University, First Faculty of Medicine, Institute of Hygiene and Epidemiology, Prague Center for Global Health, Prague, Czech Republic.

Trisha Jigar Dhabalia (TJ)

Charles University, First Faculty of Medicine, Institute of Hygiene and Epidemiology, Prague Center for Global Health, Prague, Czech Republic.

Lada L Roslycky (LL)

Black Trident Defence and Security Consulting Group LLC, Sheridan, Wyoming, USA.

James M Wilson V (JM)

M2 Medical Intelligence, Inc., Reno, Nevada, USA.

Jan-Cedric Hansen (JC)

StratAdviser Ltd., Paris, France.

Olesya Hulchiy (O)

P.L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.

Olga Golubovskaya (O)

Bogomolets National Medical University, Kyiv, Ukraine.

Mykola Buriachyk (M)

P.L. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine.

Kondratiuk Vadim (K)

Military Medical Clinical Center of North Region of Ukraine, Kharkiv, Ukraine.

Rostyslav Zauralskyy (R)

Efferent Medicine Department, Kremenchuk Maternity Hospital, Kremenchuk, Poltava, Ukraine.

Oleg Vyrva (O)

Bone Tumor Department, Ukrainian National Academy of Medical Sciences, Sytenko Institute of Spine and Joint Pathology, Kharkiv, Ukraine.

Dmytro Stepanskyi (D)

Department of Microbiology, Virology, Immunology and Epidemiology, Dnipro Medical Academy of the Ministry of Health of Ukraine, Dnipro, Ukraine.

Pokhil Sergiy Ivanovitch (PS)

Laboratory of New and Little-Explored Infections Disease, Mechnikov Institute of Microbiology and Immunology, National Academy of Medical Sciences of Ukraine, Kharkiv, Ukraine.

Alla Mironenko (A)

Department of Respiratory & Viral Infections, L.V. Gromashevsky Institute of Epidemiology & Infectious Diseases, National Academy of Medical Science of Ukraine, National Influenza Center, Kyiv, Ukraine.

Volodymyr Shportko (V)

Ukrainian Military Medical Academy, Kyiv, Ukraine.

John E McElligott (JE)

Maricopa County Medical Society, Phoenix, Arizona, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH